Literature DB >> 20662044

American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis.

Jennifer M Grossman1, Rebecca Gordon, Veena K Ranganath, Chad Deal, Liron Caplan, Weiling Chen, Jeffrey R Curtis, Daniel E Furst, Maureen McMahon, Nivedita M Patkar, Elizabeth Volkmann, Kenneth G Saag.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20662044     DOI： 10.1002/acr.20295

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN： 2151-464X            Impact factor:   4.794


× No keyword cloud information.
  209 in total

1.  Trends and Determinants of Osteoporosis Treatment and Screening in Patients With Rheumatoid Arthritis Compared to Osteoarthritis.

Authors:  Gulsen Ozen; Diane L Kamen; Ted R Mikuls; Bryant R England; Frederick Wolfe; Kaleb Michaud
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-03-11       Impact factor: 4.794

Review 2.  Complications of long-term therapy for ANCA-associated systemic vasculitis.

Authors:  Nadezhda Wall; Lorraine Harper
Journal:  Nat Rev Nephrol       Date:  2012-06-05       Impact factor: 28.314

3.  Bone: the conundrum of glucocorticoid-induced osteoporosis.

Authors:  Steven L Teitelbaum
Journal:  Nat Rev Endocrinol       Date:  2012-06-12       Impact factor: 43.330

Review 4.  My treatment approach to rheumatoid arthritis.

Authors:  John M Davis; Eric L Matteson
Journal:  Mayo Clin Proc       Date:  2012-07       Impact factor: 7.616

5.  Comorbidities: glucocorticoids and osteoporosis: predicting fracture risk.

Authors:  Stanley B Cohen
Journal:  Nat Rev Rheumatol       Date:  2010-12       Impact factor: 20.543

6.  Fractures and Subsequent Graft Loss and Mortality among Older Kidney Transplant Recipients.

Authors:  Megan L Salter; Xinran Liu; Sunjae Bae; Nadia M Chu; Alexandra Miller Dunham; Casey Humbyrd; Dorry L Segev; Mara A McAdams-DeMarco
Journal:  J Am Geriatr Soc       Date:  2019-05-06       Impact factor: 5.562

Review 7.  The pathogenesis, treatment and prevention of osteoporosis in men.

Authors:  Leif Mosekilde; Peter Vestergaard; Lars Rejnmark
Journal:  Drugs       Date:  2013-01       Impact factor: 9.546

8.  Chronic low-dose glucocorticoid inhalatory therapy as a cause of bone loss in a young man: case report.

Authors:  Anna Capozzi; Silvia Della Casa; Barbara Altieri; Alfredo Pontecorvi
Journal:  Clin Cases Miner Bone Metab       Date:  2013-09

9.  Evaluation and management of the premenopausal woman with low BMD.

Authors:  Adi Cohen; Elizabeth Shane
Journal:  Curr Osteoporos Rep       Date:  2013-12       Impact factor: 5.096

Review 10.  Prevention and treatment of bone changes associated with exposure to glucocorticoids.

Authors:  Amy H Warriner; Kenneth G Saag
Journal:  Curr Osteoporos Rep       Date:  2013-12       Impact factor: 5.096
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.